ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $358,578 | +24.0% | 5,295 | +31.0% | 0.00% | 0.0% |
Q2 2023 | $289,214 | -18.5% | 4,041 | -21.0% | 0.00% | 0.0% |
Q1 2023 | $354,824 | +28.9% | 5,112 | +25.9% | 0.00% | 0.0% |
Q4 2022 | $275,200 | -28.9% | 4,059 | -42.5% | 0.00% | 0.0% |
Q3 2022 | $387,000 | -5.1% | 7,064 | +14.4% | 0.00% | 0.0% |
Q2 2022 | $408,000 | -35.9% | 6,173 | -35.6% | 0.00% | -50.0% |
Q1 2022 | $637,000 | -76.6% | 9,591 | -79.4% | 0.00% | -66.7% |
Q4 2021 | $2,717,000 | -6.2% | 46,633 | -3.4% | 0.01% | -14.3% |
Q3 2021 | $2,898,000 | -2.4% | 48,252 | -2.6% | 0.01% | -12.5% |
Q2 2021 | $2,969,000 | +45.8% | 49,561 | +21.0% | 0.01% | +33.3% |
Q1 2021 | $2,037,000 | -5.7% | 40,967 | -5.2% | 0.01% | 0.0% |
Q4 2020 | $2,159,000 | -33.4% | 43,199 | -27.0% | 0.01% | -40.0% |
Q3 2020 | $3,241,000 | +34.5% | 59,143 | +29.9% | 0.01% | +25.0% |
Q2 2020 | $2,409,000 | -1.4% | 45,545 | -16.7% | 0.01% | -20.0% |
Q1 2020 | $2,442,000 | +19.9% | 54,668 | +33.9% | 0.01% | +42.9% |
Q4 2019 | $2,036,000 | +17.6% | 40,842 | +5.1% | 0.01% | +16.7% |
Q3 2019 | $1,732,000 | +16.1% | 38,854 | +7.5% | 0.01% | 0.0% |
Q2 2019 | $1,492,000 | -4.5% | 36,144 | -6.5% | 0.01% | 0.0% |
Q1 2019 | $1,562,000 | -4.0% | 38,653 | -9.8% | 0.01% | -14.3% |
Q4 2018 | $1,627,000 | +464.9% | 42,854 | +421.9% | 0.01% | +600.0% |
Q2 2018 | $288,000 | +0.3% | 8,211 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $287,000 | +38.6% | 8,211 | +37.6% | 0.00% | 0.0% |
Q4 2017 | $207,000 | -84.7% | 5,967 | -69.9% | 0.00% | -90.0% |
Q1 2015 | $1,357,000 | -10.3% | 19,825 | -7.7% | 0.01% | -9.1% |
Q4 2014 | $1,512,000 | -5.4% | 21,490 | -3.9% | 0.01% | -8.3% |
Q3 2014 | $1,598,000 | -74.7% | 22,365 | -73.7% | 0.01% | -62.5% |
Q2 2014 | $6,313,000 | -9.8% | 84,950 | -21.2% | 0.03% | -39.6% |
Q1 2014 | $6,997,000 | +14.2% | 107,850 | +4.5% | 0.05% | +3.9% |
Q4 2013 | $6,126,000 | +7.5% | 103,190 | -10.1% | 0.05% | +70.0% |
Q3 2013 | $5,697,000 | +110.9% | 114,800 | +101.1% | 0.03% | +3.4% |
Q2 2013 | $2,701,000 | – | 57,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |